Animals

Costa Rica-made plasma shown to inhibit coronavirus, ready for clinical trials: UCR Alejandro Zúñiga The Tico Times Costa Rica

Costa Rica is set to begin clinical trials on antibody-rich plasma that has been extracted from horses with the purpose of treating COVID-19 patients.

Two versions of the plasma were shown to inhibit the infectivity of SARS-CoV-2, the virus that causes COVID-19, in tests performed at the National Center for Biodefense and Infectious Diseases in the United States. 

CLICK HERE - STUDY - Transmissibility of emerging viral zoonoses

outbreaknewstoday.com - November 21, 2018

Researchers have developed a model that predicts which of the viruses that can jump from animals to people can also be transmitted from person to person–and are therefore possible sources of human diseases.

The study, published recently in PLOS One, identified several viruses that are not yet known to spread among humans but may have that potential, suggesting possible targets for future disease surveillance and research efforts.

(CLICK HERE - READ COMPLETE ARTICLE)

ALSO SEE RELATED ARTICLE HERE - Pub Med - Transmissibility of emerging viral zoonoses

documents.worldbank.org - 29 January 2018

Abstract

Public health systems have critical and clear relevance to the World Bank’s twin goals of poverty eradication and boosting shared prosperity. In particular, they are impacted by, and must respond to,significant threats at human-animal-environment interface. Most obvious are the diseases shared between humans and animals (“zoonotic” diseases), which comprise more than 60 percent of known human infectious pathogens; but also aspects of vector-borne disease, food and water safety and security, and antimicrobial resistance. Public health systems must therefore be resilient and prepared to face existing and future disease threats at the human-animal-environment interface. the Operational Framework provides a strong orientation to One Health to assist users in understanding and implementing it, from rationale to concrete guidance for its application. Six core chapters are included, supported by annexes diving deeper into operational tools and recent World Bank alignment with One Health topics, and a glossary that explains key terms, including interpretations specific to the Operational Framework.